# Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

> **NCT03703856** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 53 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT03703856
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-31
- **Primary completion:** 2025-01-08
- **Final completion:** 2025-12-30
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703856, "Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03703856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*